Authors
Loading...
This review discusses mitochondrial dysregulation in cancer progression and therapeutic approaches, suggesting novel mitochondrial-targeted strategies.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: